• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Menopausal Hot Flashes - Pipeline Review, H1 2012 Product Image

Menopausal Hot Flashes - Pipeline Review, H1 2012

  • ID: 2092610
  • March 2012
  • 58 pages
  • Global Markets Direct

Menopausal Hot Flashes – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H1 2012', provides an overview of the Menopausal Hot Flashes therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. 'Menopausal Hot Flashes - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Menopausal Hot Flashes.
- A review of the Menopausal Hot Flashes products under development by READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Menopausal Hot Flashes Overview
Therapeutics Development
An Overview of Pipeline Products for Menopausal Hot Flashes
Menopausal Hot Flashes Therapeutics under Development by Companies
Menopausal Hot Flashes Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Menopausal Hot Flashes Therapeutics – Products under Development by Companies
Menopausal Hot Flashes Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Menopausal Hot Flashes Therapeutics Development
Depomed, Inc.
Noven Pharmaceuticals, Inc.
Bionovo, Inc.
Radius Health, Inc.
DSM Nutritional Products AG
Pherin Pharmaceuticals, Inc.
Menopausal Hot Flashes – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Serada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mesafem - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RAD1901 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Menerba - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acupuncture + Gabapentin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pregabalin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Megestrol Acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Citalopram hydrobromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prometrium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PH80-HF - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gabapentin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Menopausal Hot Flashes Therapeutics – Drug Profile Updates
Menopausal Hot Flashes Therapeutics – Discontinued Products
Menopausal Hot Flashes Therapeutics - Dormant Products
Menopausal Hot Flashes – Product Development Milestones
Featured News & Press Releases
Nov 16, 2011: Bionovo To Begin Dosing In Menerba Phase III Clinical Trial For Menopausal Hot Flashes
Oct 26, 2011: Bionovo Initiates Menerba Phase III Clinical Trial For Menopausal Hot Flashes
Oct 13, 2011: Depomed Announces Top-Line Results From Serada Phase III Trial BREEZE 3 In Menopausal Hot Flashes
Aug 30, 2011: Bionovo Announces Positive Results From Tolerability Trial Of Menerba For Menopausal Hot Flashes
Jul 25, 2011: Bionovo Announces Successful Completion Of Animal Toxicology Studies For MF101
May 03, 2011: Pfizer Announces Results From Phase III Efficacy Sub-Study Of PRISTIQ
Mar 28, 2011: Bionovo Initiates Enrollment In Menerba Phase I 'Tolerability' Clinical Trial For Menopausal Hot Flushes
Mar 03, 2011: Depomed Completes Enrollment Of Breeze 3 Phase III Clinical Trial for Non-Hormonal Treatment in Menopausal Hot Flashes
Feb 10, 2011: Bionovo Announces 2011 Plan Of Action On MF101
Feb 02, 2011: DSM Nutritional Products's GeniVida Reduces Hot Flashes and Night Sweats In Postmenopausal Women
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Menopausal Hot Flashes, H1 2012
Products under Development for Menopausal Hot Flashes – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Depomed, Inc., H1 2012
Noven Pharmaceuticals, Inc., H1 2012
Bionovo, Inc., H1 2012
Radius Health, Inc., H1 2012
DSM Nutritional Products AG, H1 2012
Pherin Pharmaceuticals, Inc., H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Menopausal Hot Flashes Therapeutics – Drug Profile Updates
Menopausal Hot Flashes Therapeutics – Discontinued Products
Menopausal Hot Flashes Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Menopausal Hot Flashes, H1 2012
Products under Development for Menopausal Hot Flashes – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos